superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-12-31
- Valid until
- 2024-12-31
- Published
- 2024-02-20
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 40,871,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "AstraZeneca total equity: 39,166,000,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_91657DA81B37, https://asof.is/claim/clm_91657DA81B37, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm.
APA
AsOf. (2023). AstraZeneca total equity: 39,166,000,000 United States dollar (as of 2023-12-31 (until 2024-12-31)) [Record clm_91657DA81B37]. Retrieved November 9, 2026, from https://asof.is/claim/clm_91657DA81B37 (source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm)
BibTeX
@misc{asof_clm_91657DA81B37,
author = {AsOf},
title = {AstraZeneca total equity: 39,166,000,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_91657DA81B37}},
note = {Claim clm\_91657DA81B37, as of 2023-12-31 (until 2024-12-31); source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_91657DA81B37.md/v1/claims/clm_91657DA81B37submit a correction